F. C. F. de Brito

Cilostazol exerts antiplatelet and anti-inflammatory effects through AMPK activation and NF-kB inhibition on hypercholesterolemic rats.

Nadia Alice Vieira da Motta, F. C. F. de Brito, 2016, Fundamental & clinical pharmacology.

Design, synthesis and pharmacological evaluation of novel pyrazolo[3,4-b]thieno[2,3-d]pyridine acid derivatives: a new class of anti-inflammatory and anti-platelet agents.

F. C. F. de Brito, E. Barreiro, C. Fraga, 2002, Bioorganic & medicinal chemistry letters.

Novel phthalimide derivatives, designed as leukotriene D(4) receptor antagonists.

F. C. F. de Brito, L. M. Lima, E. Barreiro, 2002, Bioorganic & medicinal chemistry letters.

Anti-atherogenic effects of a new thienylacylhydrazone derivative, LASSBio-788, in rats fed a hypercholesterolemic diet.

Nadia Alice Vieira da Motta, F. C. F. de Brito, E. Barreiro, 2013, Journal of pharmacological sciences.

EVALUATION OF THE EFFECTS PRODUCED BY SUBACUTE TRIBUTYLTIN ADMINISTRATION ON VASCULAR REACTIVITY OF MALE WISTAR RATS.

F. C. F. de Brito, D. C. Magliano, L. Miranda-Alves, 2021, Toxicology.

Inhibition of inflammatory pathways promotes an improving effect on endothelial dysfunction: The effects of Longxuetongluo capsule in an experimental model of atherosclerosis.

F. C. F. de Brito, 2016, Atherosclerosis.

Subacute administration of cilostazol modulates PLC-γ/PKC-α/p38/NF-kB pathway and plays vascular protective effects through eNOS activation in early stages of atherosclerosis development.

F. C. F. de Brito, Stephani Correia Brazão, Lis Jappour Autran, 2023, Life sciences.